Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0AD4H
|
|||
Former ID |
DCL000747
|
|||
Drug Name |
Cethrin
|
|||
Synonyms |
Quinacrine, Dihydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Spinal cord injury [ICD-11: ND51.2] | Phase 1/2 | [1] | |
Company |
Alseres Pharmaceuticals Purchased rights for Cethrin from BioAxone Therapeutic
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H32Cl3N3O
|
|||
Canonical SMILES |
CCN(CC)CCCC(C)NC1=CC(=CC2=C1C=C3C=C(C=CC3=N2)OC)Cl.Cl.Cl
|
|||
InChI |
1S/C23H30ClN3O.2ClH/c1-5-27(6-2)11-7-8-16(3)25-22-14-18(24)15-23-20(22)13-17-12-19(28-4)9-10-21(17)26-23;;/h9-10,12-16,25H,5-8,11H2,1-4H3;2*1H
|
|||
InChIKey |
QKAZHUGLNKCCGY-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
SuperDrug ATC ID |
P01AX05
|
|||
SuperDrug CAS ID |
cas=000083896
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Rho-associated protein kinase (ROCK) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Emerging drugs for spinal cord injury. Expert Opin Emerg Drugs. 2008 Mar;13(1):63-80. | |||
REF 2 | A phase I/IIa clinical trial of a recombinant Rho protein antagonist in acute spinal cord injury. J Neurotrauma. 2011 May;28(5):787-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.